Grants per year
Personal profile
Research Interests
My interests include treating primary brain tumors such as gliomas and meningiomas. I also have a specific interest in metastatic disease to the brain from systemic cancers such as melanoma, lung and breast cancer and lead multiple trials in both primary brain tumors and metastatic disease. I am interested in providing novel care to my patients while maintaining quality of life.
Certifications and Licenses
| Neurology |
Training Experience
| 2008 | Internship, Evanston Hospital |
| 2011 | Residency, Northwestern University, McGaw Medical Center |
| 2012 | Fellowship, Northwestern University, McGaw Medical Center |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
MD, Northeastern Ohio University
… → 2007
Research interests
- Brain Cancer / Nervous System Cancer
- Neuro-Oncology
- Neurology
Fingerprint
Dive into the research topics where Priya U Kumthekar is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Advances in the Diagnosis and Treatment of Leptomeningeal Disease
Sharma, A., Low, J. T. & Kumthekar, P., Jul 2022, In: Current neurology and neuroscience reports. 22, 7, p. 413-425 13 p.Research output: Contribution to journal › Review article › peer-review
-
Editorial commentary: Society for Neuro-Oncology 2021 Annual Meeting updates on primary central nervous system tumors
Singer, L. & Kumthekar, P., Jun 2022, In: Chinese clinical oncology. 11, 3, 18.Research output: Contribution to journal › Article › peer-review
Open Access -
Leptomeningeal metastases: the future is now
Lukas, R. V., Thakkar, J. P., Cristofanilli, M., Chandra, S., Sosman, J. A., Patel, J. D., Kumthekar, P., Stupp, R. & Lesniak, M. S., Feb 2022, In: Journal of Neuro-Oncology. 156, 3, p. 443-452 10 p.Research output: Contribution to journal › Review article › peer-review
-
Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance)
Galanis, E., Anderson, S. K., Twohy, E., Butowski, N. A., Hormigo, A., Schiff, D., Omuro, A., Jaeckle, K. A., Kumar, S., Kaufmann, T. J., Geyer, S., Kumthekar, P. U., Campian, J., Giannini, C., Buckner, J. C. & Wen, P. Y., Jan 1 2022, In: Neuro-Oncology Advances. 4, 1, vdac041.Research output: Contribution to journal › Article › peer-review
Open Access -
Targeting HER2+ Breast Cancer Brain Metastases: A Review of Brain-Directed HER2-Directed Therapies
Chiec, L. & Kumthekar, P., Feb 2022, In: CNS Drugs. 36, 2, p. 167-179 13 p.Research output: Contribution to journal › Review article › peer-review
2 Scopus citations